Preventing second stroke with blood thinners in narrowed brain arteries
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests a combination of blood thinners to prevent another stroke in people who have a narrowed artery in the brain. It compares standard treatment to a combination of low-dose blood thinners to see if this approach works better to prevent future strokes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are over 40 years old.
- You had a recent ischemic stroke (clot-caused stroke) or a high-risk mini-stroke within the past 30 days.
- The stroke or mini-stroke is likely due to a narrowing of at least one major artery inside your brain, as seen on imaging.
- You are able to do your daily activities with little to no help (modified Rankin Score less than 4).
- You do not have another reason needing long-term blood thinners (like a heart valve or recent stent).
- You do not have advanced kidney disease, low platelets, or uncontrolled high blood pressure.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a combination of two blood thinners (antiplatelet drugs) to see if they work better than one in people who had a mild stroke caused by a narrowed artery in the brain. If you had a recent first stroke and are otherwise healthy, you may be able to join.
This trial tests whether giving a clot-dissolving medicine (alteplase or tenecteplase) is safe and effective for people who have had a stroke and are taking a blood thinner (DOAC) like apixaban or rivaroxaban. It aims to see if this treatment can still be given within a few hours of the stroke.
This trial tests if ticagrelor or cilostazol is better at preventing a second stroke in people who have had their first mild to moderate ischemic stroke. It aims to find which treatment works best within the first 24 hours of symptoms.
This trial is testing whether a combination of two medicines—colchicine (an anti-inflammatory) and a low dose of rivaroxaban (a blood thinner)—can help prevent future heart attacks, strokes, or other blood vessel problems in people who recently had a stroke caused by a blood clot.
This trial tests whether combining aspirin with a second antiplatelet drug (ticagrelor or clopidogrel) helps prevent another stroke after a mild stroke or TIA. It might lower your risk of having another event.
This study compares two types of blood-thinning medicines to see which one is better at preventing another stroke in people who had a stroke without a clear cause. It may help if you had a stroke recently and have certain heart-related risk factors.
Hear when a new Ischemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.